Emerging Oncology Trends Dramatic advances within the last decade have reshaped the global oncology market. A record number of new cancer drugs have received regulatory approval. Some of these treatments, such as immunotherapies, have permanently altered the way we approach cancer treatment. Yet while the global oncology market has enjoyed many triumphs, the industry continues […]

Although clinicians and drug manufacturers have always touted the value of certain treatments, cost-effectiveness hasn’t always been an integral part of the pharma market. However, priorities have shifted in recent years and value-based pricing has begun to dominate the US pharma market. As market access shifts, pharma companies must change their business model or risk […]

Pharma and biotech companies thrive on communication with key opinion leaders (KOLs). However, connecting with these individuals can be a challenge. Identifying your outreach goals helps eliminate logistic roadblocks. Once you have your organization’s goals in mind, you can seek out individuals who can help you on the path to success. Read on to learn […]

As conference season winds down, you can still squeeze value out of your conference experiences. Among the big reasons to attend a major oncology conference are the opportunities you have to make new connections and cultivate new relationships, and the chance to get a leg up on the newest information in your field. To get […]

Each year, the medical industry uncovers exciting new data that can help in the fight against cancer. However, this information isn’t always distributed effectively. Yet stakeholders desperately need access to the latest clinical data. If they aren’t able to locate these data, patients may not benefit from the new insights. Information gaps have a tremendous […]

At Aptitude Health, we strive to understand patterns of care that affect cancer patients not enrolled in clinical trials. We identify factors influencing prescribing habits that shape best practices and essentially get to the why. CASES Summits are regional events where approximately 60 oncologists and hematologists from large community practices, along with leading scientific experts, […]

Pharmaceutical companies often put a tremendous amount of effort into connecting with prominent oncologists. These key stakeholders can indeed offer a wealth of information. Oncologists, in particular, can provide pharmaceutical companies with valuable insights into what factors guide their treatment decisions. However, many clinicians are now withdrawing from these discussions. Heavy caseloads and tight schedules […]

After some of the important 2019 conferences have come to an end, it’s time to reevaluate your product’s or corporate messaging and decide how it fits within the trending insights and newsworthy industry knowledge you gathered from your experiences. Learning about the appropriate evolution of your marketing message post-congress is key to maintaining its buzz—from […]

In today’s fast-paced world, it can be hard to schedule in-person meetings with stakeholders. Yet medical companies face more pressure than ever to connect with stakeholders, or risk missing out on valuable networking opportunities. Virtual collaboration platforms have emerged to help fill this gap. Savvy marketers can now use modern technology to meet stakeholders with […]

When life science companies visualize their ideal key opinion leaders (KOLs) for cancer treatments, they typically think of oncologists and/or hematologists. But in their rush to connect with skilled physicians, many pharmaceutical companies in the United States overlook a vital resource: the rest of the oncology care team. Cancer patients don’t receive care from an […]